These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8754795)
21. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation. Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K Endocrinology; 1995 Mar; 136(3):842-8. PubMed ID: 7867592 [TBL] [Abstract][Full Text] [Related]
22. Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells. Udagawa N; Sasaki T; Akatsu T; Takahashi N; Tanaka S; Tamura T; Tanaka H; Suda T Biochem Biophys Res Commun; 1992 Apr; 184(1):67-72. PubMed ID: 1567458 [TBL] [Abstract][Full Text] [Related]
23. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286 [TBL] [Abstract][Full Text] [Related]
24. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. Granholm S; Henning P; Lindholm C; Lerner UH Bone; 2013 Jan; 52(1):83-92. PubMed ID: 23017661 [TBL] [Abstract][Full Text] [Related]
25. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Nagai M; Sato N Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850 [TBL] [Abstract][Full Text] [Related]
26. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. Nakamura I; Tanaka H; Rodan GA; Duong LT Endocrinology; 1998 Dec; 139(12):5182-93. PubMed ID: 9832459 [TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. Wang L; Mao YJ; Wang WJ Yao Xue Xue Bao; 2006 Jun; 41(6):555-60. PubMed ID: 16927832 [TBL] [Abstract][Full Text] [Related]
29. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185 [TBL] [Abstract][Full Text] [Related]
30. Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. Linkhart TA; Linkhart SG; Kodama Y; Farley JR; Dimai HP; Wright KR; Wergedal JE; Sheng M; Beamer WG; Donahue LR; Rosen CJ; Baylink DJ J Bone Miner Res; 1999 Jan; 14(1):39-46. PubMed ID: 9893064 [TBL] [Abstract][Full Text] [Related]
31. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix. Otsuka E; Kato Y; Hirose S; Hagiwara H Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289 [TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of bone resorption activity of osteoclast-like cells by measuring calcium phosphate resorbing area using incubator-facilitated and video-enhanced microscopy. Morimoto Y; Hoshino H; Sakurai T; Terakawa S; Nagano A Microsc Res Tech; 2009 Apr; 72(4):317-22. PubMed ID: 19003898 [TBL] [Abstract][Full Text] [Related]
34. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Li H; Miyahara T; Tezuka Y; Namba T; Suzuki T; Dowaki R; Watanabe M; Nemoto N; Tonami S; Seto H; Kadota S Biol Pharm Bull; 1999 Apr; 22(4):391-6. PubMed ID: 10328560 [TBL] [Abstract][Full Text] [Related]
35. The role of LFA-1 in osteoclast development induced by co-cultures of mouse bone marrow cells and MC3T3-G2/PA6 cells. Tani-Ishii N; Penninger JM; Matsumoto G; Teranaka T; Umemoto T J Periodontal Res; 2002 Jun; 37(3):184-91. PubMed ID: 12113552 [TBL] [Abstract][Full Text] [Related]
36. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921 [TBL] [Abstract][Full Text] [Related]
37. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. Nakamura I; Takahashi N; Sasaki T; Tanaka S; Udagawa N; Murakami H; Kimura K; Kabuyama Y; Kurokawa T; Suda T FEBS Lett; 1995 Mar; 361(1):79-84. PubMed ID: 7890044 [TBL] [Abstract][Full Text] [Related]
38. Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone. Yuhara S; Kasagi S; Inoue A; Otsuka E; Hirose S; Hagiwara H Eur J Pharmacol; 1999 Nov; 383(3):387-93. PubMed ID: 10594333 [TBL] [Abstract][Full Text] [Related]